Abstract
Get full access to this article
View all access options for this article.
References
1.
Gustafsson
LL
Walker
O
Alvan
G
Beermann
B
Estevez
F
Gleisner
L
Disposition of chloroquine in man after single intravenous and oral doses . Br J Clin Pharmacol
1983 ;15 :471 –9 .
2.
Kitchen
SF
. Vivax malaria . In:
Boyd
MF
, ed. Malariology . Philadelphia : WB Saunders
1949 :1027 –45 .
3.
Looareesuwan
S
White
NJ
Chanthavanich
P
Edwards
G
Nicholl
DD
Bunch
C
Cardiovascular toxicity and distribution kinetics of intravenous chloroquine . Br J Clin Pharmacol
1986 ;22 :31 –6 .
4.
Phillips-Howard
PA
ter Kuile
FO
. CNS adverse events associated with antimalarial agents . Fact or fiction? Drug Saf
1995 ;12 :370 –83 .
5.
Naranjo
CA
Busto
U
Sellers
EM
Sandor
P
Ruiz
I
Roberts
EA
A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther
1981 ;30 :239 –45 .
6.
Lange
WR
Frankenfield
DL
Moriarty-Sheehan
M
Contoreggi
CS
Frame
JD
. No evidence for chloroquine-associated retinopathy among missionaries on long-term malaria chemoprophylaxis . Am J Trop Med Hyg
1994 ;51 :389 –92 .